Andecaliximab/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: Results from a phase 1 study. (Q52565553)
Jump to navigation
Jump to search
scientific article published on 24 April 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Andecaliximab/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: Results from a phase 1 study. |
scientific article published on 24 April 2018 |
Statements
Andecaliximab/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: Results from a phase 1 study. (English)
Heinz-Josef Lenz
Manish A Shah
Alexander N Starodub
Sunil Sharma
Jordan Berlin
Manish R Patel
Zev A Wainberg
Jorge Chaves
Michael S Gordon
Kevin Windsor
Carrie Baker Brachmann
Xi Huang
Greg Vosganian
Julia D Maltzman
Victoria Smith
Jeffrey A Silverman
Johanna C Bendell
24 April 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference